Results 111 to 120 of about 1,521,832 (315)

Federal lead action plan to reduce lead exposures [PDF]

open access: yes
fed-lead-action-plan-reduce-lead-exposures-508 ...

core  

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

High Blood Lead Levels as A Risk Factor of Stunting: A Study of Children in Agricultural Areas

open access: yesJurnal Kesehatan Lingkungan
Introduction: The prevalence of stunting among student aged children in Indonesia is relatively high (24.5%). Stunting can threaten the quality of human resources one day.
Alfan Afandi   +4 more
doaj   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Hippo pathway at the crossroads of stemness and therapeutic resistance in breast cancer

open access: yesMolecular Oncology, EarlyView.
Dysregulation of the Hippo pathway drives nuclear accumulation of YAP/TAZ, activating stemness‐related transcriptional programs that sustain breast cancer stemness and fuel therapeutic resistance across subtypes, underscoring Hippo signaling as a targetable vulnerability. Figure created and edited with BioRender.com.
Giulia Schiavoni   +11 more
wiley   +1 more source

Lead [PDF]

open access: yes
Summary of health effects, exposure, and recommendations in an easy-to-read magazine format.CS242227-AWhat is lead? -- Lead and the environment -- Exposure to lead -- Lead and the body -- Health effects of exposure -- Lead and children -- Reducing risk ...

core  

E2A selectively regulates TGF‐β–induced apoptosis in KRAS‐mutant non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Ability to induce apoptosis by TGF‐β is frequently lost in advanced lung adenocarcinoma despite intact TGF‐β signaling. We identify E2A as a mutant KRAS–dependent mediator of resistance to TGF‐β–induced apoptosis. TGF‐β induces E2A via SMAD3 in mutant KRAS cells, and E2A silencing restores apoptosis and enhances radiation response in cell lines ...
Sergei Chuikov   +3 more
wiley   +1 more source

Beta-Adrenergic Receptor Density and Adenylate Cyclase Activity in Lead- Exposed Rat Brain after Cessation of Lead Exposure

open access: yes, 2008
To understanding the reversible or irreversible harm to the beta- adrenergic system in the brain of lead-exposed rats, this study sets up an animal model to estimate the change in the sympathetic nervous system of brain after lead exposure was withdrawn.
CHANG, HUOY-ROU;TSAO, DER-AN;YU, HSIN- SU;HO, CHI-KUNG   +1 more
core  

CD47 promotes mitogen‐activated protein kinase and epithelial‐to‐mesenchymal transition molecular programs to drive prometastatic phenotypes in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Beyond its role in immune evasion, this study identified that CD47 drives tumor‐intrinsic signaling in non‐small cell lung cancer (NSCLC). Transcriptomic profiling and functional studies revealed that CD47 regulates cell adhesion, migration, and metastasis through an ERK–EMT signaling axis.
Asa P.Y. Lau   +8 more
wiley   +1 more source

Time to Ban Lead in Industrial Paints and Coatings

open access: yesFrontiers in Public Health, 2015
Perry eGottesfeld
doaj   +1 more source

Home - About - Disclaimer - Privacy